Therapeutic indications

Avelumab is indicated for:

Metastatic Merkel cell carcinoma (MCC)

Irrespective of gender only Adults (18 years old or older)

Avelumab is indicated as monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC).

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 10 mg/kg once every 2 weeks

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines